The IPO Buzz: Prime Medicine & Mobileye
Momentum may be the word of the day. Prime Medicine, Inc. (PRME proposed) – a pre-clinical gene editing company – plans to raise $151.3 million this week. Mobileye Global (MBLY proposed), Intel’s self-driving car unit, may be up next. The Wall Street Journal reported late Monday (Oct. 17, 2022) that Mobileye is likely to cut […]
October 17, 2022 Read More